BlackRock Fund Advisors’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $5K | Sell |
2,812
-194,790
| -99% | -$346K | ﹤0.01% | 4075 |
|
|
2016
Q3 | $656K | Buy |
197,602
+1,967
| +1% | +$6.53K | ﹤0.01% | 3256 |
|
|
2016
Q2 | $841K | Sell |
195,635
-262,538
| -57% | -$1.13M | ﹤0.01% | 3273 |
|
|
2016
Q1 | $2.58M | Buy |
458,173
+13,433
| +3% | +$75.6K | ﹤0.01% | 3000 |
|
|
2015
Q4 | $7.65M | Sell |
444,740
-903
| -0.2% | -$15.5K | ﹤0.01% | 2600 |
|
|
2015
Q3 | $9.4M | Buy |
445,643
+12,075
| +3% | +$255K | ﹤0.01% | 2407 |
|
|
2015
Q2 | $21.5M | Sell |
433,568
-65,026
| -13% | -$3.22M | 0.01% | 2070 |
|
|
2015
Q1 | $39M | Buy |
498,594
+11,894
| +2% | +$931K | 0.01% | 1675 |
|
|
2014
Q4 | $29.5M | Buy |
486,700
+42,410
| +10% | +$2.57M | 0.01% | 1832 |
|
|
2014
Q3 | $18.9M | Buy |
444,290
+20,231
| +5% | +$862K | 0.01% | 1987 |
|
|
2014
Q2 | $26.2M | Sell |
424,059
-8,211
| -2% | -$507K | 0.01% | 1849 |
|
|
2014
Q1 | $28.1M | Buy |
432,270
+41,357
| +11% | +$2.69M | 0.01% | 1808 |
|
|
2013
Q4 | $22M | Buy |
390,913
+15,626
| +4% | +$880K | 0.01% | 1939 |
|
|
2013
Q3 | $23M | Buy |
375,287
+51,500
| +16% | +$3.16M | 0.01% | 1880 |
|
|
2013
Q2 | $18.9M | Buy |
+323,787
| New | +$18.9M | 0.01% | 1892 |
|